The Oslo based technology transfer offices Medinnova and Birkeland Innovasjon have merged. The new company is named Inven2. Jostein Dalland has been appointed CEO of Inven2. As of January 1, 2011, the company will be co-located at Oslo Innovation Center in one of the most concentrated physical campuses for bio-medical activity in the Nordic countries, Gaustadbekkdalen.